Skip to content

Clinical trials

Scleroderma, Systemic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Country / region: United States Clear all

162 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20013
20022
20031
20041
20054
20063
20077
20087
20095
20104
20116
20123
20134
20142
20157
20168
20175
20185
20197
20204
20216
20225
202311
202410
202518
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed81
Recruiting30
Terminated23
Active, not recruiting12
Not yet recruiting5
Unknown status4
Withdrawn3
Suspended2
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Michigan10
Northwestern University5
Duke University4
Fred Hutchinson Cancer Center4
Hospital for Special Surgery, New York4
National Institute of Allergy and Infectious Diseases (NIAID)4
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)4
Stanford University4
Boehringer Ingelheim3
Boston University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic162
Scleroderma, Diffuse71
Autoimmune Diseases27
Lupus Erythematosus, Systemic25
Arthritis, Rheumatoid17
Lung Diseases, Interstitial17
Dermatomyositis16
Myositis15
Lupus Nephritis14
Connective Tissue Diseases12

Trials

Showing 1 to 25 of 162. Each trial links to its page on Pharma Observatory.

62 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.